According to the data from phase 3 clinical trials of the drug in 250 patients across 10 sites, the "drug works best in ...

The Drugs Controller General of India (DCGI) has suspended the approval granted to Mumbai-based Entod Pharmaceuticals for ...

The Directorate General of Health Services (DGHS), under the Central Drugs Standard Control Organisation (CDSCO), has ...

The decision follows the company’s claims that its drops could reduce the dependency on reading glasses for individuals ...

Entod Pharmaceuticals denies making false claims about their new PresVu eye drops and plans to challenge the suspension by ...

The Central Drugs Standard Control Organisation (CDSCO) said that it was suspending its approval for the pilocarpine ...

DCGI suspends Entod Pharma`s eye drop permission for presbyopia treatment due to unapproved claims. The company will ...

Entod Pharma to challenge DCGI's suspension of permission for PresVu in court: Our Bureau, New Delhi Thursday, September 12, 2024, 13:45 Hrs [IST] Entod Pharmaceuticals announced ...

Taking serious note of Mumbai-based Entod Pharmaceuticals' claims that it can help reduce dependency on reading glasses for ...

In response to the various alleged misleading claims made by Entod Pharma in respect to its Opthalmologic product, Drugs ...

The Drugs Controller General of India (DCGI) stated in an order dated September 10 that the Directorate had approved on August 20 for the production and distribution of Pilocarpine Hydrochloride ...

In an order issued on Tuesday, the Drugs Controller General of India (DCGI) said it issued permission on August 20 to manufacture and market Pilocarpine Hydrochloride Ophthalmic Solution , the ...